The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events. - Wikidata - wikimedia - TriplyDB

The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events.

The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events.

http://www.wikidata.org/entity/Q33693990

about

Comparative clinical implications of admission electrocardiographic findings for patients with non-ST-segment elevation myocardial infarction.PLA1A2 platelet polymorphism predicts mortality in prediabetic subjects of the population based KORA S4-Cohort The PlA1/A2 polymorphism of glycoprotein IIIa as a risk factor for stroke: a systematic review and meta-analysis.The PlA1/A2 polymorphism of glycoprotein IIIa as a risk factor for myocardial infarction: a meta-analysis.Association between obesity and high blood pressure among Lithuanian adolescents: a cross-sectional study.Association of adiponectin with hepatic steatosis: a study of 1,349 subjects in a random population sample Platelet glycoprotein IIIa Leu33Pro gene polymorphism and coronary artery disease: A meta-analysis of cohort studies.Association Between Vascular Access Dysfunction and Subsequent Major Adverse Cardiovascular Events in Patients on Hemodialysis: A Population-Based Nested Case-Control Study A Meta-Analysis of Randomized Controlled Trials on Antiplatelet Agents Versus Placebo/Control for Treating Peripheral Artery Disease.Genetic Association Studies Reporting on Variants in the C-Reactive Protein Gene and Coronary Artery Disease: A Meta-Analysis.Cardiac Rehabilitation in Real Life.Fixed-Dose Combinations of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in the Treatment of Hypertension: A Comparison of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors Inverse Association of Serum Docosahexaenoic Acid With Newly Diagnosed Hypertension: A Community-based Case-control Study Association Between Estimated 24-h Urinary Sodium Excretion and Metabolic Syndrome in Korean Adults: The 2009 to 2011 Korea National Health and Nutrition Examination Survey.Prognostic Value of Plasma Intermedin Level in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Association of Genetic Polymorphisms on VEGFA and VEGFR2 With Risk of Coronary Heart Disease Angiogenesis in chronic obstructive pulmonary disease: a translational appraisal Aspiration Thrombectomy and Drug-Eluting Stent Implantation Decrease the Occurrence of Angina Pectoris One Year After Acute Myocardial Infarction.The Prognostic Role of Angiotensin II Type 1 Receptor Autoantibody in Non-Gravid Hypertension and Pre-eclampsia: A Meta-analysis and Our Studies Estimated Glomerular Filtration Rate and Systolic Time Intervals in Risk Stratification for Increased Left Ventricular Mass Index and Left Ventricular Hypertrophy.Effect of multiple clinical factors on recurrent angina after percutaneous coronary intervention: A retrospective study from 398 ST-segment elevation myocardial infarction patients.Elevated plasma migration inhibitory factor in hypertension-hyperlipidemia patients correlates with impaired endothelial function.Increased mean aliphatic lipid chain length in left ventricular hypertrophy secondary to arterial hypertension: A cross-sectional study.Serum lipocalin-2 levels are positively associated with not only total body fat but also visceral fat area in Chinese men.Clinical impact of genetically determined platelet reactivity.Genetically Determined Platelet Reactivity and Related Clinical Implications.Common genetic variants in platelet surface receptors and its association with ischemic stroke.Proton pump inhibitor use by aspirin-treated coronary artery disease patients is not associated with increased risk of cardiovascular events.Diabetes and new-onset atrial fibrillation in a hypertensive population.Retrospective analysis of prognosis and risk factors of patients with stroke by TOAST.Interankle Systolic Blood Pressure Difference Is a Marker of Prevalent Stroke in Chinese Adults: A Cross-Sectional Study.

P2860

Q33595369-13C4FC55-7C49-40B7-9426-6EC92E92A3DC Q33617402-0ADFEA43-6BFA-4A1E-B7F8-54B442737F7A Q33836873-CE6E3E5B-60F7-478E-9A86-4E27B338E9C4 Q33838453-9609A5D9-EF1F-4D9E-93AF-3CA90B6D82F9 Q34694334-3AD28AC6-6222-4D7F-8040-DD339170A739 Q35137985-C2568437-F908-43C0-AAFF-2F8BC1AE802F Q35234099-97E855EC-E905-4F20-99B9-A295F47F0180 Q35858118-F37805ED-F7B3-4881-A2AC-D1AD7D91C09B Q36194774-5DDF3BF8-F1A2-40A8-AA72-C752652E6AFE Q36195002-DCCC7BC9-E646-46DC-BA5D-2719CB36BBCB Q36195105-EA707DC1-31ED-4394-A49C-B7D86F89D851 Q36421103-09B4BE6D-4CD5-46E6-AE42-CE807AFB0EA1 Q36566748-F62B3927-07DD-4DD8-A10C-B838BC47C919 Q36822281-D4B88B59-F464-44E0-A29F-73B1534D07A6 Q36838073-3906D19B-3BD7-4475-8A0C-C896B4560852 Q36993344-ECD9B09C-448A-4E0D-B1DC-DB0DAF0C93E5 Q37058368-47741357-37D3-403A-80E3-D0CEFF1E5EB8 Q37206349-02656658-304E-478E-A071-612FD0761212 Q37206448-41B2B2C7-712D-4A5D-80BD-08CC1928351B Q37206993-EAC18993-28A5-488B-9C09-3194DF820705 Q37354759-34975E6F-DE3E-49D8-BFD0-00208E0E8EA3 Q37384162-8974C7AA-1099-4E3F-B2F3-77973D5D5099 Q37432845-26AFD2B0-3655-4A1E-91C4-8BAB11AC64DC Q37605558-30224878-AF41-4633-AFA3-DCE37E3984EB Q38059616-918AA360-6D4A-4371-9269-5F53310C3C85 Q38489014-C1A7E5A0-4112-442F-B747-8A4AF0E39884 Q38857206-1F3848CF-7BE7-43D0-9F8C-13E56BE8A548 Q39482145-F726CEBA-C19C-4DAD-B102-0247DFDFEC1C Q40873653-FF8E15C9-A60C-41C9-84BA-2454AF257032 Q52593830-81BEA591-EDB7-4F03-9CE3-9E424801D452 Q53982375-32DC49AD-35EB-475C-89F6-4188DB4B7DB2

P2860

The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events.

http://www.wikidata.org/entity/Q33693990

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

The GPIIIA PlA2 polymorphism i ...... cardiovascular adverse events.

@ast

The GPIIIA PlA2 polymorphism i ...... cardiovascular adverse events.

@en

type

label

The GPIIIA PlA2 polymorphism i ...... cardiovascular adverse events.

@ast

The GPIIIA PlA2 polymorphism i ...... cardiovascular adverse events.

@en

prefLabel

The GPIIIA PlA2 polymorphism i ...... cardiovascular adverse events.

@ast

The GPIIIA PlA2 polymorphism i ...... cardiovascular adverse events.

@en

P1433

Q33693990-A4071213-0726-4352-998F-2796C31169E6

P1476

Q33693990-EA13EF44-764D-4A56-BE73-CBA01021F675

P2093

Q33693990-25ED050D-2173-4B63-BE8B-613F0C91D6DF

Q33693990-352D3444-C8C2-4AFC-940A-A797D52312B9

Q33693990-474F5DEF-ECFB-4E43-9A14-16598E482E26

Q33693990-601FC23A-10D6-40BE-A4A4-142F532B4926

Q33693990-87551489-6466-4BDC-A04B-6243AAC20EE6

Q33693990-8C29D1C5-2D1A-416A-9DF8-19CB225E9BBF

Q33693990-9D587772-78D1-4049-93C2-34F4B60A2BE1

Q33693990-A584587D-CCE1-472B-992F-407B332FA206

Q33693990-E0A17031-E188-48EE-9724-65CEACDE5189

Q33693990-E636C163-9D60-48DE-943B-DF9DEF8302DB

P2860

Q33693990-1DAC8EC8-15E4-4F03-86B7-7DDC7454FD95

Q33693990-28333D57-46FF-49D0-A5CA-DDC4BC7CD3EA

Q33693990-2F127C3E-14CA-47EC-9CAD-3ECCB2C7E44C

Q33693990-35A04570-E7C1-449C-A375-CEEFC267E9B3

Q33693990-3AB2D49C-0138-4CB0-8690-28184D0B9766

Q33693990-4D1080D5-94BC-4ACA-A9AF-F35A64FDFB61

Q33693990-50C352D5-601D-4709-B679-AB6D8E41D52E

Q33693990-6F275A09-2E50-4EA7-A073-252BE0E4F1C4

Q33693990-88AF8686-70CF-4033-9021-96F24E19CF4E

Q33693990-8A1852F4-2B10-4878-B2E2-B31F64817D05

P2888

Q33693990-1C3236F7-92DB-495F-9755-77E858D8B513

P304

Q33693990-94CB9D65-1173-4B74-8278-833F77FE46C5

P31

Q33693990-502A2CB1-817D-4095-B5EC-48B56D08FED4

P356

Q33693990-9FE1F6FA-6164-4AA3-B1F0-13F7CCFD6501

P478

Q33693990-2532D706-F44B-410A-B6CC-B890CC7A6310

P577

Q33693990-79F3FE99-A3D8-4E05-9A1D-00956E4B60A6

P5875

Q33693990-ECEE8E15-341B-4CA1-A95C-9B4056B44F1B

P6179

Q33693990-47FB215F-69E0-4AA5-8C58-E2BF83719B74

P698

Q33693990-CE8E0B09-A9E8-4841-8F21-2C3ECDD59995

P921

Q33693990-0B283F52-3439-46A7-9250-0220C2D8F588

P932

Q33693990-82CA3FAF-5868-4479-ABA8-63CCD7DE28EF

P356

1471-2261-10-41

P1433

BMC Cardiovascular Disorders

P1476

The GPIIIA PlA2 polymorphism i ...... cardiovascular adverse events.

@en

P2093

Bruno Trimarco

http://www.w3.org/2001/XMLSchema#string

Federico Piscione

http://www.w3.org/2001/XMLSchema#string

Gaetano Santulli

http://www.w3.org/2001/XMLSchema#string

Gennaro Galasso

http://www.w3.org/2001/XMLSchema#string

Guido Iaccarino

http://www.w3.org/2001/XMLSchema#string

Massimo Chiariello

http://www.w3.org/2001/XMLSchema#string

Raffaele Piccolo

http://www.w3.org/2001/XMLSchema#string

Roberta De Rosa

http://www.w3.org/2001/XMLSchema#string

Salvatore Cassese

http://www.w3.org/2001/XMLSchema#string

Valentina Trimarco

http://www.w3.org/2001/XMLSchema#string

P2860

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment

On the structure and function of platelet integrin alpha IIb beta 3, the fibrinogen receptor

Final report on the aspirin component of the ongoing Physicians' Health Study

Platelet PlA2 polymorphism and thromboembolic events: from inherited risk to pharmacogenetics.

The integrin alpha IIb/beta 3 in human platelet signal transduction.

The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing.

Mechanisms of disease: The genetic basis of coronary heart disease.

Platelet activation and atherothrombosis.

The use of a telematic connection for the follow-up of hypertensive patients improves the cardiovascular prognosis.

Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine.

P2888

1471-2261-10-41

P304

41

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2261-10-41

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46287604

http://www.w3.org/2001/XMLSchema#string

P6179

1029367584

http://www.w3.org/2001/XMLSchema#string

P698

20846430

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

P932

2954874

http://www.w3.org/2001/XMLSchema#string